General Information of Drug (ID: DMKZ6U2)

Drug Name
TAK-426
Indication
Disease Entry ICD 11 Status REF
Zika virus infection 1D48 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DY9CP0

References

1 ClinicalTrials.gov (NCT03343626) Safety, Immunogenicity and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants. U.S. National Institutes of Health.